Functional subsets of mouse natural killer cells

被引:189
作者
Hayakawa, Yoshihiro
Huntington, Nicholas D.
Nutt, Stephen L.
Smyth, Mark J.
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Sir Donald & Lady Trescowick Labs, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
关键词
natural killer cell; cytokine; chemokine; cytotoxicity; migration; differentiation;
D O I
10.1111/j.1600-065X.2006.00454.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human natural killer (NK) cells can be divided into two phenotypically distinct functional subsets based on their cell surface expression of CD56 (CD56(bright) and CD56(dim)). As mouse NK cells do not express CD56, comparable mouse NK cell subsets have proven difficult to identify. Recently, we have found that mouse NK cells can be subdivided by the expression of CD27. The CD27(hi) and CD27(lo) mouse NK cell subsets show some intriguing similarities to but also some distinct differences from the human CD56 NK cell subsets in terms of their function and phenotype. Extending our knowledge of mature NK cell heterogeneity between the species will be critical to further our understanding of the pathological role of NK cells in immune responses.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 70 条
[1]   IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1 [J].
Barlic, J ;
Sechler, JM ;
Murphy, PM .
BLOOD, 2003, 102 (10) :3494-3503
[2]   SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 [J].
CALIGIURI, MA ;
MURRAY, C ;
ROBERTSON, MJ ;
WANG, E ;
COCHRAN, K ;
CAMERON, C ;
SCHOW, P ;
ROSS, ME ;
KLUMPP, TR ;
SOIFFER, RJ ;
SMITH, KA ;
RITZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :123-132
[3]   FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS [J].
CALIGIURI, MA ;
ZMUIDZINAS, A ;
MANLEY, TJ ;
LEVINE, H ;
SMITH, KA ;
RITZ, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1509-1526
[4]   Potential role for interleukin-15 in the regulation of human natural killer cell survival [J].
Carson, WE ;
Fehniger, TA ;
Haldar, S ;
Eckhert, K ;
Lindemann, MJ ;
Lai, CF ;
Croce, CM ;
Baumann, H ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :937-943
[5]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[6]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[7]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[8]   In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells [J].
Cooper, MA ;
Bush, JE ;
Fehniger, TA ;
VanDeusen, JB ;
Waite, RE ;
Liu, Y ;
Aguila, HL ;
Caligiuri, MA .
BLOOD, 2002, 100 (10) :3633-3638
[9]   Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset [J].
Cooper, MA ;
Fehniger, TA ;
Turner, SC ;
Chen, KS ;
Ghaheri, BA ;
Ghayur, T ;
Carson, WE ;
Caligiuri, MA .
BLOOD, 2001, 97 (10) :3146-3151
[10]   Natural killer cell developmental pathways: A question of balance [J].
Di Santo, James P. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :257-286